Powering Advancements
in Heart Health

The ability to detect cardiac biomarkers at ultra-low levels is advancing the future of heart health.

Simoa assays can detect cardiac biomarkers, which are instrumental for predicting major adverse cardiovascular events, development of heart failure or transition to end-stage kidney disease, earlier than ever before. Further, the ability to detect minute changes in these biomarkers enables the identification of at-risk patients earlier in their disease progression to guide more personalized, preventive care. 

Latest News

View the recording of the panel discussion “Precision Cardiovascular Medicine: What is Different This Time” which took place at the World Medical Innovation Forum on May 2, 2017
Carrie Fisher’s recent heart failure (in addition to the passing of her iconic mother Debbie Reynolds) reminds us all how much this country struggles with heart disease, where it's the leading cause of death. In a fascinating attempt to curb this issue, one Massachusetts-based company is creating

Request to Learn More